Gasdermin-D and Pannexin-1 in Pregnancy

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

May 15, 2022

Study Completion Date

May 30, 2022

Conditions

Pregnancy ComplicationsMaternal Obesity

Interventions

DIAGNOSTIC_TEST

Biomarker measurement of pannexin-1 and gasdermin-D

These biomarkers were measured in the placental and adipose tissues of the participants.

Trial Locations (1)

Haseki Training and Research Hospital, Sultangazi

All Listed Sponsors

lead

Haseki Training and Research Hospital

OTHER

NCT05475951 - Gasdermin-D and Pannexin-1 in Pregnancy | Biotech Hunter | Biotech Hunter